Clinical Trials
- Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis
- Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis
- Case-Control Study to Identify Risk Factors for Microscopic Colitis
- Systems Biology of Gastrointestinal and Related Diseases
- Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis
- Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant
- Etiology of Lymphopenia in Covid19 Infection
- Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
- InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort
- InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )
- InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-O )
- InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort)
- InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort
- Lymphocyte Count as a Sign of Immunoparalysis and Its Correlation With Nutritional Status in Septic Pediatric Patients
- Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19
- Pyridostigmine as Immunomodulator in People Living With HIV
- Regional Differences in Human Immunodeficiency Virus (HIV) Testing
- Safety Study of IL-7 in HIV-infected Patients (Inspire)
- Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer
- Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
- Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas
- Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
- Large Cell Lymphoma Pilot Study III
- MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma
- MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma
- Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas
- PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma
- A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
- Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
- Biomarkers in Samples From Patients With Endometrial Cancer
- Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients
- Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
- Chromoendoscopy to Decrease the Risk of Colorectal Neoplasia in Lynch Syndrome
- Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients, CORAL Study
- Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
- Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer
- Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Patients Meeting Chinese Lynch Syndrome Criteria
- Direct Information to At-risk Relatives
- DNA Adductomics for Colorectal Cancer Investigation
- Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer
- Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome
- Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
- Evaluating the Cologuard Test for Use in Lynch Syndrome
- Evaluation of ArTificial Intelligence System (Gi-Genius) for adenoMa dEtection in Lynch Syndrome.
- Faecal Microbiota Characterization in Lynch Syndrome (LS) Patients With or Without Colorectal Neoplasia
- Familial Colorectal Cancer Registry in Hispanics
- Family History Study on Cancer Risk
- Feasibility Study: IGNITE-TX (Identifying Texans at Risk for Hereditary Cancer) Intervention
- Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome
- Genetic Risk: Whether, When, and How to Tell Adolescents
- Hereditary Nonpolyposis Colorectal Cancer in Taiwan－Related Genetic Study and Clinical Applications
- High Definition White-Light Colonoscopy vs. Chromoendoscopy for Surveillance of Lynch Syndrome.
- I-Scan For Colon Polyp Detection In HNPCC
- Identifying and Caring for Individuals With Inherited Cancer Syndrome
- Identifying Patients With Hereditary and Familial Colorectal Cancer by Using an Online Risk Tool
- Implementation of a New Strategy to Identify HNPCC Patients
- Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
- Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting
- Linked Color Imaging Versus High-definition White Light Endoscopy for the Detection of Polyps in Patients With Lynch Syndrome (LCI-LYNCH)
- Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation
- Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
- Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes
- Molecular Screening for Lynch Syndrome in Denmark
- Molecular Screening for Lynch Syndrome in Southern Denmark
- MSI in Circulatory DNA of Endometrial Cancer
- Multi-Organ Screening Recommendations in Patients With Lynch Syndrome
- Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
- NBI Versus Indigo Carmine During Colonoscopy in Lynch Syndrome
- Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy
- Ohio Colorectal Cancer Prevention Initiative
- Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
- Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
- PD-1 Antibody Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
- PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients
- Pediatric Reporting of Adult-Onset Genomic Results
- Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome
- Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
- Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer
- Prostate Cancer Genetic Risk Evaluation and Screening Study
- Prostate Cancer Screening Among Men With High Risk Genetic Predisposition
- Psychosocial Aspects of Genetic Testing for Hereditary Nonpolyposis Colon Cancer
- Registry for Women Who Are At Risk Or May Have Lynch Syndrome
- Scalable Communication Modalities for Returning Genetic Research Results
- Telemedicine vs. Face-to-Face Cancer Genetic Counseling
- Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
- The GEOLynch Cohort Study
- Trial to Compare eConsent With Standard Consent Among Prospective Biobank Participants
- Uncertain Genetic Test Results for Lynch Syndrome
- Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care
- Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer
- Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families
- A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
- Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
- Biomarkers in Samples From Patients With Endometrial Cancer
- Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients
- Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
- Chromoendoscopy to Decrease the Risk of Colorectal Neoplasia in Lynch Syndrome
- Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients, CORAL Study
- Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
- Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer
- Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Patients Meeting Chinese Lynch Syndrome Criteria
- Direct Information to At-risk Relatives
- DNA Adductomics for Colorectal Cancer Investigation
- Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer
- Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome
- Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
- Evaluating the Cologuard Test for Use in Lynch Syndrome
- Evaluation of ArTificial Intelligence System (Gi-Genius) for adenoMa dEtection in Lynch Syndrome.
- Faecal Microbiota Characterization in Lynch Syndrome (LS) Patients With or Without Colorectal Neoplasia
- Familial Colorectal Cancer Registry in Hispanics
- Family History Study on Cancer Risk
- Feasibility Study: IGNITE-TX (Identifying Texans at Risk for Hereditary Cancer) Intervention
- Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome
- Genetic Risk: Whether, When, and How to Tell Adolescents
- Hereditary Nonpolyposis Colorectal Cancer in Taiwan－Related Genetic Study and Clinical Applications
- High Definition White-Light Colonoscopy vs. Chromoendoscopy for Surveillance of Lynch Syndrome.
- I-Scan For Colon Polyp Detection In HNPCC
- Identifying and Caring for Individuals With Inherited Cancer Syndrome
- Identifying Patients With Hereditary and Familial Colorectal Cancer by Using an Online Risk Tool
- Implementation of a New Strategy to Identify HNPCC Patients
- Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
- Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting
- Linked Color Imaging Versus High-definition White Light Endoscopy for the Detection of Polyps in Patients With Lynch Syndrome (LCI-LYNCH)
- Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation
- Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
- Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes
- Molecular Screening for Lynch Syndrome in Denmark
- Molecular Screening for Lynch Syndrome in Southern Denmark
- MSI in Circulatory DNA of Endometrial Cancer
- Multi-Organ Screening Recommendations in Patients With Lynch Syndrome
- Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
- NBI Versus Indigo Carmine During Colonoscopy in Lynch Syndrome
- Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy
- Ohio Colorectal Cancer Prevention Initiative
- Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
- Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
- PD-1 Antibody Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
- PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients
- Pediatric Reporting of Adult-Onset Genomic Results
- Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome
- Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
- Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer
- Prostate Cancer Genetic Risk Evaluation and Screening Study
- Prostate Cancer Screening Among Men With High Risk Genetic Predisposition
- Psychosocial Aspects of Genetic Testing for Hereditary Nonpolyposis Colon Cancer
- Registry for Women Who Are At Risk Or May Have Lynch Syndrome
- Scalable Communication Modalities for Returning Genetic Research Results
- Telemedicine vs. Face-to-Face Cancer Genetic Counseling
- Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
- The GEOLynch Cohort Study
- Trial to Compare eConsent With Standard Consent Among Prospective Biobank Participants
- Uncertain Genetic Test Results for Lynch Syndrome
- Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care
- Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer
- Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families